A $20.3 million quarterly loss was narrower, but SelectQuote revenue fell to $280 million.

SelectQuote reported a narrower Q1 loss of $20.3M but revenue fell to $280M. Revenue declined in both Senior and Healthcare Services segments. The company reaffirmed FY2027 guidance, expecting revenue between $1.35B and $1.45B. CEO Tim Danker cited operational efficiencies and AI-driven improvements as key growth drivers.

Original reporting
Published Nov 4, 2026, 12:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 12:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$SLQT
Relevance
8/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

Med
01

Why it matters

Earnings miss and lower revenue may weigh on the stock, while guidance offers a potential upside if targets are met.

02

Market read

First earnings release for the quarter; provides fresh data for traders.

03

What to watch

Guidance range suggests upside potential if Medicare Advantage growth accelerates.

Relevance 8/10Novelty 8/10Timing: Q1 FY2027 earnings release

Background

SelectQuote reported Q1 FY2027 results with a $20.3M loss and $280M revenue, providing guidance for FY2027.

Market effects

Insurance brokerage earnings may influence health insurance sector sentiment.

U.S. health insurance brokerage market.

Limited to U.S. insurance brokerage sector.

Counterpoint

Despite a narrower loss, revenue decline could pressure the stock.

Key entities

  • SelectQuote

    U.S. health insurance brokerage reporting earnings.

Related articles

$SLQTMed

SelectQuote Inc (SLQT) (Q1 2027) Earnings Call Highlights: Beats EBITDA and Cash Flow

SelectQuote Inc (SLQT) reported Q1 2027 earnings, beating EBITDA and cash flow estimates. President Bob noted stable plan termination and high beneficiary engagement. CFO Ryan Clement highlighted progress toward a $60M operating cash flow target, with potential future cash dividends. CEO Tim Danker mentioned strong front-end production and improved recapture rates. The company is expanding its Olathe facility and investing in technology for other sites.

$SLQTMedAI 8/10

SelectQuote places fewer Medicare policies but earns more on each one

SelectQuote (SLQT) approved 18% fewer Medicare Advantage policies in Q1 2027, with revenue falling to $280M from $329M. However, commission values per policy rose 16% to $890. The company is shrinking its agent force to improve efficiency, and adjusted EBITDA losses narrowed. Healthcare Services revenue fell 16% but adjusted EBITDA rose 56%. SelectQuote maintained its full-year guidance and faces a False Claims Act lawsuit.

$SLQTMed

What SelectQuote (SLQT) Said on Its Q1 Earnings Call

SelectQuote (SLQT) reported Q1 earnings, with Senior revenue declining to $51M from $59M, but adjusted EBITDA loss narrowing. Healthcare Services revenue fell to $186M, while adjusted EBITDA rose 56% to $11M. Life Insurance revenue declined to $43M, but adjusted EBITDA increased 31% to $7M. The company plans a reverse stock split and invests in AI and technology. Management noted stability in commissions and potential carrier marketing efforts.

$SLQTMed

SelectQuote (SLQT) Q1 2027 Earnings Call Transcript

SelectQuote (SLQT) reported a Q1 2027 adjusted EBITDA loss of $17M, improved from last year. Revenue was $280M, down 15% YoY. Senior segment lost $12M (improved $9M YoY), while Healthcare Services EBITDA rose 56% YoY to $11M. The company reiterated its fiscal 2027 operating cash flow target of at least $60M, citing strong profitability and cash flow performance.

$SLQTMedAI 8/10

SelectQuote (SLQT) Q1 2027 Earnings Call Transcript

SelectQuote (SLQT) reported Q1 2027 revenue of $280M, down 15% YoY, with an adjusted EBITDA loss of $17M. Senior revenue fell 14% YoY, while Medicare Advantage policies decreased 18%. Healthcare Services revenue dropped 16%, but EBITDA grew 56%. The company maintained full-year guidance and plans a reverse stock split. Management prioritized profitability over volume, leveraging AI and operational efficiencies.